Pay in 4 interest-free payments of $7.35 Learn more
Ships within 48 hours · Estimated delivery Oct 22 - Oct 27
Opportunities Expanding Use in Obesity Management The growing use of GLP-1 analogues for the treatment of obesity is one of the largest opportunities
Enrollment was defined as randomization, with participants assigned within each cohort in a 6:2 ratio to receive PG-102 or a placebo
These medications include semaglutide (Ozempic, Wegovy, Rybelsus), liraglutide (Victoza, Saxenda), and dulaglutide (Trulicity)
Typically it starts with a textural difference you can only feel
We over-recruited due to unknown levels of data quality
US$ 27.09
US$ 26.83
US$ 20.08
US$ 21.85
US$ 20.02
